Jennifer Buell - 21 Feb 2025 Form 4 Insider Report for AGENUS INC (AGEN)

Role: Director
Signature: /s/Christine M. Klaskin, as Attorney-in-Fact for Jennier Buell
Issuer symbol: AGEN
Transactions as of: 21 Feb 2025
Net transactions value: +$1,809
Form type: 4
Filing time: 11 Mar 2025, 16:05:04 UTC
Previous filing: 18 Feb 2025
Next filing: 24 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGEN	Common Stock	Award	$1,809	+545	+3.7%	$3.32	15,237	21 Feb 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	At her request and with the approval of the Agenus Inc. Compensation Committee, a portion of Jennifer Buell's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Buell's salary for the pay period ending February 21, 2025. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.
F2	$3.32 is the closing price of our Common Stock on February 21, 2025, the payroll date for the pay period ending February 21, 2025.

Content

At her request and with the approval of the Agenus Inc. Compensation Committee, a portion of Jennifer Buell's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Buell's salary for the pay period ending February 21, 2025. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

$3.32 is the closing price of our Common Stock on February 21, 2025, the payroll date for the pay period ending February 21, 2025.